NCT00240838View on ClinicalTrials.gov

An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.

PHASE4CompletedINTERVENTIONAL

Enrollment

483

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

June 30, 2003

Conditions

Pain

Interventions

DRUG

acetaminophen extended release caplets

All Listed Sponsors

lead

Johnson & Johnson Consumer and Personal Products Worldwide

INDUSTRY

NCT00240838 - An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness. | Biotech Hunter | Biotech Hunter